HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma

被引:126
作者
Han, Liz Y. [1 ]
Fletcher, Mavis S. [5 ]
Urbauer, Diana L. [2 ]
Mueller, Peter [2 ]
Landen, Charles N. [1 ]
Kamat, Aparna A. [1 ]
Lin, Yvonne G. [1 ]
Merritt, William M. [1 ]
Spannuth, Whitney A. [1 ]
Deavers, Michael T. [3 ]
De Geest, Koen [6 ]
Gershenson, David M. [1 ]
Lutgendorf, Susan K. [7 ]
Ferrone, Soldano [8 ]
Sood, Anil K. [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[5] Univ Nebraska, Dept Pathol, Omaha, NE 68182 USA
[6] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA
[7] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA
[8] SUNY Buffalo, Roswell Pk Canc Ctr, Dept Immunol, Buffalo, NY USA
关键词
D O I
10.1158/1078-0432.CCR-07-4433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Defects in the antigen processing machinery (APM) may provide tumor cells with a mechanism to escape immune recognition. The purpose of this study is to determine the clinical significance of APM component down-regulation and tumor-infiltrating T cells in ovarian carcinoma. Experimental Design: After institutional review board approval, tumor samples from 150 patients with invasive epithelial ovarian cancers were examined for TAP1,TAP2, tapasin, HLA class I heavy chain (HLA-HC), beta 2 microglobulin, and T-cell (CD3(+) and CD8(+)) tumor infiltration using immunohistochemistry. Results: The majority of tumors had either heterogeneous or positive expression of TAP1,TAP2, HLA-HC, and 32 microglobulin (66.7%, 73.3%,70.7%, and 63.3%, respectively), except tapasin for which 58% of the tumors lacked expression. Furthermore, 67% and 88% of the lesions possessed intratumoral and peritumoral CD3(+) or CD8(+) cells, respectively. The majority of APM component expression examined was significantly associated with both intratumoral and peritumoral T-cell infiltration (P < 0.05). The expression of APM components and the presence of intratumoral T-cell infiltrates were significantly associated with improved survival (all P <= 0.01); however, peritumoral T-cell infiltrates did not significantly affect survival (P = 0.33). APM component down-regulation (P < 0.001), lack of intratumoral T-cell infiltrates (P = 0.03), and suboptimal cytoreduction (P < 0.001) were independent prognostic markers for death from ovarian carcinoma. Conclusion: The negative effect of APM component down-regulation by itself and in combination with absent intratumoral T-cell infiltration on the survival of patients with ovarian carcinoma implies a role for immune escape in addition to immunosurveillance in the clinical course of disease.
引用
收藏
页码:3372 / 3379
页数:8
相关论文
共 38 条
  • [1] Ovarian cancer: Strategies for overcoming resistance to chemotherapy
    Agarwal, R
    Kaye, SB
    [J]. NATURE REVIEWS CANCER, 2003, 3 (07) : 502 - 516
  • [2] [Anonymous], CANC FACTS FIG 2007
  • [3] Mhc class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma
    Atkins, D
    Breuckmann, A
    Schmahl, GE
    Binner, P
    Ferrone, S
    Krummenauer, F
    Strökel, S
    Seliger, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (02) : 265 - 273
  • [4] The structure of the T cell antigen receptor
    Bentley, GA
    Mariuzza, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 563 - 590
  • [5] Cancer immunotherapy: A treatment for the masses
    Blattman, JN
    Greenberg, PD
    [J]. SCIENCE, 2004, 305 (5681) : 200 - 205
  • [6] HLA class I antigen loss, tumor immune escape and immune selection
    Campoli, M
    Chang, CC
    Ferrone, S
    [J]. VACCINE, 2002, 20 : A40 - A45
  • [7] HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
    Chang, CC
    Campoli, M
    Ferrone, S
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (05) : 644 - 650
  • [8] Cooper BC, 2002, CLIN CANCER RES, V8, P3193
  • [9] Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors
    Facoetti, A
    Nano, R
    Zelini, P
    Morbini, P
    Benericetti, E
    Ceroni, M
    Campoli, M
    Ferrone, S
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8304 - 8311
  • [10] Molecular interactions between extracellular components of the T-cell receptor signaling complex
    Garcia, KC
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 172 : 73 - 85